Human γδ T cells also combine IFN‐γ production with cytotoxicity, and have been shown to kill renal cell carcinoma [44], squamous cell carcinoma [45], colon cell carcinoma [45, 46], and acute [47] and chronic myeloid leukemia cells [48], among various other tumor types [49]. The gene discussed is IFNG; the disease is neoplasm.